Literature DB >> 2145814

Persistent etretinate levels in plasma after changing the therapy to acitretin.

W E Lambert1, A P De Leenheer, J P De Bersaques, A Kint.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2145814     DOI： 10.1007/bf00375730

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  5 in total

1.  Etretinate. Persistent serum levels after long-term therapy.

Authors:  J J DiGiovanna; L A Zech; M E Ruddel; G Gantt; G L Peck
Journal:  Arch Dermatol       Date:  1989-02

2.  Embryopathy in infant conceived one year after termination of maternal etretinate.

Authors:  E J Lammer
Journal:  Lancet       Date:  1988-11-05       Impact factor: 79.321

3.  Malformation of fetus conceived 4 months after termination of maternal etretinate treatment.

Authors:  W Grote; D Harms; U Jänig; H Kietzmann; U Ravens; I Schwarze
Journal:  Lancet       Date:  1985-06-01       Impact factor: 79.321

4.  High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.

Authors:  A P De Leenheer; W E Lambert; J P De Bersaques; A H Kint
Journal:  J Chromatogr       Date:  1990-02-02

5.  Etretinate kinetics during chronic dosing in severe psoriasis.

Authors:  J Massarella; F Vane; C Buggé; L Rodriguez; W J Cunningham; T Franz; W Colburn
Journal:  Clin Pharmacol Ther       Date:  1985-04       Impact factor: 6.875
  5 in total
  2 in total

Review 1.  Current use and future potential role of retinoids in dermatology.

Authors:  C E Orfanos; C C Zouboulis; B Almond-Roesler; C C Geilen
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

Review 2.  Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways.

Authors:  M L Bouvy; M C Sturkenboom; M C Cornel; L T De Jong-Van den Berg; B H Stricker; H Wesseling
Journal:  Pharm Weekbl Sci       Date:  1992-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.